Since its IPO, Compass Therapeutics has been fairly volatile. From it's Covid lows, it had quite a run, gaining over 300% in a fairly short amount of time. There was heavy insider buying and very little short interest. This happened all while the overall market and indices were making the 2022 lows. It has since been on a steep downward trajectory, and I have been following it closely, looking at the $1.80's range for a possible bounce. It got down to $1.86 and has so far had a bounce. Started a position at $1.90, with a risk tolerance of .15. Watching to see if this support holds, but trying to preserve my capital if things start selling again. Looking for an initial target of $2.60.